Jeremias Wohlschlaeger Selected Research

norfenefrine

1/2005	Roles of MMP-2/-9 in cardiac dysfunction during early multiple organ failure in an ovine animal model.
7/2004	Heat shock protein 72 and apoptosis indicate cardiac decompensation during early multiple organ failure in sheep.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jeremias Wohlschlaeger Research Topics

Disease

27	Neoplasms (Cancer) 07/2021 - 01/2005
14	Malignant Mesothelioma 07/2021 - 09/2012
10	Heart Failure 02/2011 - 01/2005
6	Mesothelioma 03/2022 - 01/2016
5	Cardiomegaly (Heart Hypertrophy) 11/2010 - 01/2007
5	Hypertrophy 01/2010 - 01/2007
4	Neuroendocrine Tumors (Neuroendocrine Tumor) 04/2016 - 12/2014
4	Carcinoid Tumor (Carcinoid) 01/2016 - 01/2014
3	Necrosis 10/2020 - 09/2015
3	Lung Neoplasms (Lung Cancer) 01/2016 - 12/2014
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2015 - 01/2013
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2015 - 01/2014
3	Adenocarcinoma 09/2014 - 10/2013
3	Colorectal Neoplasms (Colorectal Cancer) 10/2013 - 07/2005
2	Inflammation (Inflammations) 01/2019 - 09/2015
2	Infections 01/2019 - 01/2008
2	Carcinoma (Carcinomatosis) 03/2018 - 01/2015
2	Atherosclerotic Plaque (Atheroma) 09/2015 - 02/2006
2	Reperfusion Injury 02/2015 - 02/2014
2	Carcinogenesis 01/2014 - 11/2006
2	Neoplasm Metastasis (Metastasis) 05/2012 - 11/2009
2	Breast Neoplasms (Breast Cancer) 06/2011 - 01/2005
2	Polyploidy 03/2010 - 03/2008
2	Cholangiocarcinoma 12/2009 - 02/2007
2	Hepatocellular Carcinoma (Hepatoma) 03/2009 - 01/2008
2	Stroke (Strokes) 04/2005 - 07/2004
2	Multiple Organ Failure (MODS) 01/2005 - 07/2004
2	Shock 01/2005 - 07/2004
2	Hypovolemia 01/2005 - 07/2004
2	Endotoxemia 01/2005 - 07/2004
1	Lymphoma (Lymphomas) 01/2019
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 09/2015
1	Ischemic Stroke 09/2015
1	Atherosclerosis 09/2015
1	Pathologic Constriction (Stenosis) 09/2015
1	Fibrosis (Cirrhosis) 09/2015
1	Coronary Artery Disease (Coronary Atherosclerosis) 09/2015
1	Lymphatic Metastasis 05/2015
1	Small Cell Carcinoma 12/2014
1	Sarcoma (Soft Tissue Sarcoma) 09/2014
1	Fatty Liver 02/2014
1	Neuroendocrine Carcinoma 01/2014

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 03/2018 - 01/2005
6	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2019 - 06/2009
6	Biomarkers (Surrogate Marker)IBA 04/2016 - 04/2008
6	Biological ProductsIBA 04/2016 - 02/2006
5	Phosphotransferases (Kinase)IBA 03/2022 - 01/2005
5	Pemetrexed (MTA)FDA Link 04/2016 - 09/2012
4	AsbestosIBA 07/2021 - 01/2016
4	MetallothioneinIBA 10/2020 - 11/2009
4	MicroRNAs (MicroRNA)IBA 06/2017 - 07/2009
4	Cyclin D1IBA 11/2010 - 01/2008
4	DNA (Deoxyribonucleic Acid)IBA 03/2010 - 04/2005
3	PlatinumIBA 07/2021 - 09/2012
3	Messenger RNA (mRNA)IBA 01/2019 - 01/2014
3	UbiquitinIBA 03/2012 - 01/2010
2	Cisplatin (Platino)FDA LinkGeneric 10/2020 - 04/2016
2	EnzymesIBA 10/2020 - 01/2019
2	RNA (Ribonucleic Acid)IBA 01/2019 - 09/2014
2	Folic Acid (Vitamin M)FDA LinkGeneric 04/2016 - 09/2014
2	Formaldehyde (Formol)FDA Link 01/2016 - 12/2013
2	ParaffinIBA 01/2016 - 12/2013
2	Transcription Factors (Transcription Factor)IBA 01/2015 - 11/2009
2	Folic Acid AntagonistsIBA 09/2014 - 09/2013
2	SurvivinIBA 11/2010 - 03/2008
2	Cell Cycle ProteinsIBA 01/2010 - 01/2010
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 02/2007 - 01/2007
2	Matrix Metalloproteinases (MMPs)IBA 02/2006 - 01/2005
2	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2005 - 01/2005
2	norfenefrineIBA 01/2005 - 07/2004
1	MitogensIBA 07/2021
1	CytokinesIBA 04/2021
1	olaparibIBA 01/2019
1	Bortezomib (Velcade)FDA Link 01/2019
1	Proteasome InhibitorsIBA 01/2019
1	Heavy MetalsIBA 04/2018
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2018
1	AntibodiesIBA 01/2016
1	Phenobarbital (Luminal)FDA Link 09/2015
1	Lipoproteins (Lipoprotein)IBA 09/2015
1	TC 13IBA 01/2015
1	ErbB Receptors (EGF Receptor)IBA 09/2014
1	Proto-Oncogene Proteins c-mdm2IBA 05/2014
1	oil red OIBA 02/2014
1	ATP dependent 26S protease (26S proteasome)IBA 01/2014
1	Investigational DrugsIBA 10/2013
1	Pharmaceutical PreparationsIBA 10/2013
1	TOR Serine-Threonine KinasesIBA 10/2013

Therapy/Procedure

11	Therapeutics 07/2021 - 01/2005
8	Heart-Assist Devices 02/2011 - 12/2005
6	Drug Therapy (Chemotherapy) 01/2019 - 09/2012
4	Transplantation 02/2014 - 12/2005
2	Art Therapy 01/2019 - 06/2017
2	Heart Transplantation (Grafting, Heart) 02/2011 - 08/2008
1	Immunotherapy 04/2021
1	Chemoradiotherapy 05/2015
1	Thoracotomy 05/2015
1	Induction Chemotherapy 05/2015
1	Kidney Transplantation 02/2015
1	Liver Transplantation 02/2014